The physiology underlying this finding is controversial, as rh-EPO administration often leads to iron deficiency [36], leading to difficulty in determining whether elevated or exogenous EPO is a cause of thrombocytosis or simply a surrogate for iron deficiency. This evidence concerns the gene EPO and Iron deficiency anemia.